A Phase I/II clinical trial evaluating COVID-19 vaccine in healthy volunteers
Latest Information Update: 03 Sep 2021
Price :
$35 *
At a glance
- Drugs HDT-301 (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 31 Aug 2021 According to HDT Bio media release, phase 1 trial has been completed.
- 24 Aug 2021 Results published in the HDT Bio Media Release.
- 09 May 2021 New trial record